1. Volume 66, Issue 5, Pages 874-880 (November 2014)
Phase 2 Trial of Neoadjuvant Axitinib in Patients with Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma 
Jose A. Karam, Catherine E. Devine, Diana L. Urbauer, Marisa Lozano, Tapati Maity, Kamran Ahrar, Pheroze Tamboli, Nizar M. Tannir, Christopher G. Wood 
European Urology 
Volume 66, Issue 5, Pages (November 2014)
DOI: /j.eururo
Copyright © 2014 European Association of Urology Terms and Conditions

2. Fig. 1 Consolidated Standards of Reporting Trials diagram.
European Urology  , DOI: ( /j.eururo )
Copyright © 2014 European Association of Urology Terms and Conditions

3. Fig. 2
Tumor diameter in centimeters, at 7 wk and 12 wk of treatment. Orange indicates partial response, and blue indicates stable disease per Response Evaluation Criteria in Solid Tumors.
European Urology  , DOI: ( /j.eururo )
Copyright © 2014 European Association of Urology Terms and Conditions

4. Fig. 3
Waterfall plot of tumor response in percentages at 12 wk of treatment. Orange indicates partial response, and blue indicates stable disease per Response Evaluation Criteria in Solid Tumors.
European Urology  , DOI: ( /j.eururo )
Copyright © 2014 European Association of Urology Terms and Conditions